Cytomx Therapeutics, Inc. · NASDAQ:CTMX

Perceptive Advisors LLC reported a 5.90% stake in Cytomx Therapeutics, Inc. (Schedule 13G)

Event Aug 14, 2025 · Filed Aug 21, 2025

Perceptive Advisors LLC reported a 5.90% stake in Cytomx Therapeutics, Inc., 9,680,185 shares, as a passive investor on Aug 14, 2025. Filed Aug 21, 2025 (Schedule 13G).

Stake
5.90%
Shares
9,680,185
Intent
Passive
What changed
Crossed above 5%
Filed together
3 holders

The filing in full

HolderStakeShares
Perceptive Advisors LLC5.90%9,680,185
Joseph Edelman5.90%9,680,185
Perceptive Life Sciences Master Fund, Ltd.5.90%9,680,185

Source

View original at SEC

Related